RSS

Reece Armstrong

Reece Armstrong Headshot

Reece Armstrong is a reporter for Digital Health Age, Medical Plastics News, European Pharmaceutical Magazine and Med-Tech Innovation. He has a MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. His interests include health, technology, videogames and he is a keen performer of live original music.

He can be contacted at reece.armstrong@rapidnews.com or through his Twitter handle @Reece92David 

NHS Trusts could face legal action if they do not enforce ‘high vigilance restrictions’ in the use of mesh following new guidance published by the National Institute of Clinical Excellence (NICE). Read more

News

At Pharmapack 2019, the interplay between pharma and medtech was more evident than ever. Regular contributor Reece Armstrong caught up with Silvia Forroova, event director of Pharmapack to find out why. Read more

News

A historical lack of transparency in the UK’s medical devices industry has led to debilitating consequences for patients, the government admitted this week. Read more

News

Regular contributor Reece Armstrong looks for the positive repercussions in what turned out to be a challenging past year for the medical device sector. Read more

Opinion

The Advanced Medical Technology Association (AdvaMed) has responded to the ‘Implant Files’ investigation, stating the stories “overlook” the positive experiences of millions of patients. Read more

News 1 Comments

Reece Armstrong examines the reasons why Ireland is a medtech hotspot and looks at what to expect from the country in the future. Read more

Opinion

Reece Armstrong examines the life science sector in North America and how innovation is at the heart of the market Read more

North America

The factory of the future is a term that has been discussed for a number of years but what exactly does it mean? Reece Armstrong explains. Read more

Opinion

Reece Armstrong looks into Netflix's latest documentary, The Bleeding Edge and examines the FDA's regulatory approvals for medical devices and why it needs to change. Read more

Opinion

In a landmark moment for thousands of women across the UK, it has been announced that the NHS will immediately halt the use of surgical mesh for treating stress urinary incontinence (SUI). Read more

News

The National Institute of Care and Excellence (NICE) is delaying its guidelines on surgical mesh despite calls to make it a matter of urgency. Read more

News

Reporter for Medical Plastics News, Reece Armstrong, has been making his way across Europe’s medtech sector to pick out some of its most exciting hotspots for innovation. Read more

Opinion

The government’s recent debate over the vaginal mesh scandal was a welcome step towards recognising the debilitating effects that women have faced from these devices. Read more

Opinion

From 25-26 April, Med-Tech Innovation Expo returns to the Ricoh Arena in Coventry to showcase the very best of the UK & Ireland’s medical technology sector. Our reporter Reece Armstrong takes a look at what's on offer at this year's show. Read more

News

With a growing demand for medical technologies all over the world and reports that markets in the east are expected to grow, MPN takes a look at what potential the Irish medtech sector has in the Middle East. Read more

Opinion

MPN takes a look at some the biggest medical device recalls that have taken place over the recent years. Read more

Devices

With the 3D printing market in healthcare set to reach €2.3 billion, there is a lot of interest surrounding the technology’s applications within the industry. Read more

News

A review into a number of medical products that have caused public scandals has been announced by the government. Read more

Devices

With an exhibitor list of 200, 28 seminars and 45 speakers, the Med-Tech Innovation Expo is set to be an exciting show for those involved in the medical technology industry. Read more

News

MPN speaks to Stratasys about how it is working together with hospitals and medical device manufacturers to improve patient outcomes and personalise treatments. Read more

Opinion